Cite
HARVARD Citation
Westhovens, R. et al. (2015). Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis. Annals of the rheumatic diseases. 74 (3), pp. 564-568. [Online].